Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Ondra Health vs Amazon One Medical

Two GLP-1 desks, one scoreboard. We put Ondra Health and Amazon One Medical head-to-head on the published Brief Score — the same six factors, scored the same way, no pay-to-win placement.

Higher Brief ScoreNo. 7 · Grade B+

Ondra Health

Visit Ondra Health Full brief →
vs
No. 14 · Grade B

Amazon One Medical

Visit Amazon One Medical Full brief →

The verdict

Ondra Health takes this head-to-head.

Ondra Health scores 87 to 86 on our six-factor Brief Score — A rare combination of a rock-bottom $93 semaglutide, brand-name access, LegitScript certification and all-50-state reach.

That doesn't make Amazon One Medical a bad call — it's best for readers who want a trusted, deep-pocketed brand and brand-name access over a published flat compounded price. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
88
80
Supply Reliability
86
90
Transparency
88
78
Access Breadth
90
88
Clinical Oversight
88
91
Track Record
82
90
Ondra HealthBrief Score 87 · 86Amazon One Medical

Price, coverage & the tracker

Ondra HealthAmazon One Medical
Brief Score87/100 (B+)86/100 (B)
Semaglutide$93/moNot disclosed
Tirzepatide$166/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableStableprice stable

Ondra Health: $93 sema / $166 tirz — the lowest accredited nationwide line we track; brand access + LegitScript.

Amazon One Medical: Brand-access model through One Medical clinicians; compounded pricing isn't published, so there's no sticker to track.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.